A company spokesperson said the ad was a "direct response" the Hims & Hers Super Bowl commercial. The ad features a vial that reads "compounded semaglutide" and a syringe. "Some compounded ...

A big part of that is related to its Super Bowl LIX ad focused ... Putting its commercial in front of all these potential customers turned out to be a good idea for Hims & Hers Health as traffic ...

An ad for compounded versions of weight-loss drug semaglutide by telehealth company Hims & Hers has attracted ... in its letter to the FDA that the commercial is "dangerous, blatantly misleading ...

Telehealth stock Hims & Hers (HIMS) spiked more than 24% in trading Thursday, days after its Super Bowl ad promoting cheaper GLP-1 weight-loss drugs sparked controversy. The ad criticized the ...

“The recent explosion in irresponsible and misleading advertising about compounded GLP-1 drugs, like the Hims & Hers Super Bowl commercial, puts patients’ safety at risk and we cannot stay ...

Shares of Hims & Hers Health, the telehealth provider that has found a niche in the obesity-drug boom, surged 28% on Thursday as the company’s controversial Super Bowl ad on Sunday continued to ...

We recently published a list of 10 Firms Post Double-Digit Gains on Thursday. In this article, we are going to take a look at where Hims & Hers Health Inc. (NYSE:HIMS) stands against other firms ...